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Intermittent Claudication?”Dear Editor,
In their editorial What is the place of surgery for
intermittent claudication?,1 Campbell and Birchley argue
that surgery can offer benefits in terms of health-related
quality of life (HRQL). However, whether surgery is in fact
a worthwhile endeavour remains unclear. The Swedish
Board of Technology Assessment in Health Care (SBU)
concluded in 2007 that there is only limited evidence for
improved HRQL by revascularisation in IC patients.
The authors suggest that decisions about interventions
for IC are unlikely to be better informed by controlled
studies due to poor patient recruitment, referring to the
MIMIC trial.2 We are convinced that Campbell and Birchley
would agree that conclusions regarding the effectiveness of
technologies are best based on controlled trials. Recruit-
ment into trials can be improved by less selective inclusion
criteria allowing open surgical and/or endovascular revas-
cularisation and also allowing invasive treatment for the
occasional non-invasive group patient that deteriorates
significantly. In a randomised study of surgical/endovas-
cular versus non-invasive treatment,3 we included approx-
imately 60% of referred claudicants 85 years. Presently,
we include 61% in a new study with similar inclusion
criteria but updated interventions.
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Response to comment on “What Is The Place Of
Surgery For Intermittent Claudication?”Dear Editor,
We thank Jivega˚rd et al for their interest in our editorial.
We do not argue that surgical revascularisation is anything
more than an option to be considered where anatomical
patterns of disease and patient choice support it. “Limited
evidence” is not the same as “No evidence” and in a field as
difficult to study scientifically as revascularisation in clau-
dication this distinction becomes the more important. In
the absence of large and definitive randomised controlled
trials we are left to make judgements about individual
patients with the available evidence.
In terms of expanding the scope of future trials, the
double-edged sword is that more lax criteria for trial entry
and types of intervention will arguably lead to reduced
certainty about the place of particular types of treatment.
We certainly do support the value of adequately poweredDOI of original article: 10.1016/j.ejvs.2010.10.012.
